Tailoring lipid nanoparticles for application-specific mRNA delivery.
Expanding the therapeutic landscape of mRNA medicines to diverse applications necessitates delivery systems tailored to distinct biological requirements. However, beyond vaccine applications, current FDA-approved lipid nanoparticles (LNPs) are often directly used as their original vaccine formulations, substantially li...